Atlas Trials

Efficacy and Safety of Intravenous YOLT-201 for Transthyretin Amyloidosis Cardiomyopathy

Clinical trial NCT06082050 · RECRUITING

Trial details

NCT number
NCT06082050
Sponsor
Zhejiang University
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Transthyroxin Amyloidosis Cardiomyopathy
Start date
2023-11-02
Primary completion
2025-07-03
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.